<p><strong>獨家報道：</strong> 據 FOX Business 瞭解，白宮預計將宣佈擴大在 TrumpRx.gov 上提供折扣的製藥公司名單。</p>
<p>最早在今天，安進和葛蘭素史克將被加入到在政府網站上提供折扣的處方藥製造商名單中。這使得在特朗普總統的壓力和關税威脅下，已有六家制藥公司簽署了最惠國定價協議，共計 54 種處方藥。</p>
<p>安進將在網站上提供一種藥物，零售價降低 80%。Amjevita 的原價為 1484 美元，但在 TrumpRx.gov 上售價為 299 美元。這種藥物用於治療類風濕關節炎、銀屑病和潰瘍性結腸炎。</p>
<p><strong>福克斯新聞民調：選民對醫療成本發出警報</strong></p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>特朗普總統在 2026 年 2 月 5 日於華盛頓特區白宮校園南法院禮堂舉行的藥品定價活動上發言，醫療保險和醫療補助服務中心的管理員 Mehmet Oz 在旁觀看。（Nathan Howard/Getty Images）</p>
<p>該公司計劃將 Aimovig 和 Repatha 的折扣定為 62%。</p>
<p>葛蘭素史克將 Incruse 的折扣定為零售價的 55%。該藥物用於治療慢性阻塞性肺病，售價為 159 美元。</p>
<p>葛蘭素史克還計劃將 Arnuity、Relenza 和 Anoro 的折扣範圍定為 10% 至 51%。</p>
<table>
<thead>
<tr>
<th>股票代碼</th>
<th>證券</th>
<th>最新</th>
<th>變動</th>
<th>變動 %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>安進</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>葛蘭素史克</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>白宮發言人 Kush Desai 對 FOX Business 表示：&#34;葛蘭素史克和安進通過 TrumpRx.gov 直接向消費者提供處方藥，以最惠國定價的方式，標誌着特朗普總統在推動藥品可負擔性方面又一個里程碑。&#34;</p>
<p>&#34;然而，TrumpRx.gov 僅僅是個開始，隨着國會通過特朗普總統的偉大醫療計劃，美國人將獲得更大的藥品價格折扣、更低的保險費和更多的透明度。&#34;</p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x"/></p>
<p>安進將在網站上提供一種藥物，零售價降低 80%。(George Frey/Bloomberg via Getty Images)</p>
<p>美國製藥研究與製造商協會代表主要製藥公司。</p>
<p>首席執行官 Stephen Ubl 認為：&#34;政府強加的最惠國政策將削弱美國的競爭力，同時對解決拒絕醫療和提高患者成本的保險做法毫無幫助。&#34;</p>
<p><strong>眾議院共和黨尋求解決數百萬美國人高昂醫療保險成本的出路</strong></p>
<p>&#34;這些政策將從美國的研發中抽走數十億美元，減緩治癒的進程，並增加對中國未來創新的依賴。&#34;</p>
<p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="931" height="523" original-src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x"/></p>
<p>葛蘭素史克將 Incruse 的折扣定為零售價的 55%。(Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
<p>白宮正在推進對 TrumpRx.gov 的公告，因為美國人正在尋找降低醫療成本的方法。</p>
<p><strong>點擊這裏獲取福克斯商業新聞移動版</strong></p>
<p>根據拜登政府的數據顯示，勞工統計局的數據表明，從 2021 年 1 月到 2025 年 1 月，處方藥成本增加了 10.4%。而在特朗普政府期間，從 2025 年 1 月到 2026 年 2 月的最新數據，處方藥價格僅增加了 0.2%。</p>

動態生物技術與基因組 ETF - Invesco

IBBQ

標普生物技術 ETF - SPDR

<p>白宮即將宣佈在 TrumpRx.gov 上擴大藥品折扣，安進和葛蘭素史克將加入這一倡議。這將使得在最惠國定價下，六家公司提供的藥物總數增加到 54 種。安進將提供高達 80% 的折扣，而葛蘭素史克將提供高達 55% 的折扣。該倡議旨在降低美國人的醫療成本，與拜登政府下藥品價格上漲形成對比。批評者認為，這類政策可能會損害美國在藥物開發方面的競爭力和創新能力</p>

<p><strong>EXCLUSIVE:</strong> The White House is expecting to announce an expansion of drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.</p>
<div class="lb-trans"><p><strong>獨家報道：</strong> 據 FOX Business 瞭解，白宮預計將宣佈擴大在 TrumpRx.gov 上提供折扣的製藥公司名單。</p>
</div><p>As early as today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government website. That makes a total of 54 prescription medications from six pharmaceutical companies that have signed on to the most-favored-nation pricing under pressure from President Donald Trump and the threat of tariffs.</p>
<div class="lb-trans"><p>最早在今天，安進和葛蘭素史克將被加入到在政府網站上提供折扣的處方藥製造商名單中。這使得在特朗普總統的壓力和關税威脅下，已有六家制藥公司簽署了最惠國定價協議，共計 54 種處方藥。</p>
</div><p>Amgen will offer medication on the website that cuts 80% off the retail price. Amjevita has an original price of $1,484, but will be available on TrumpRx.gov for $299. The medication treats rheumatoid arthritis, psoriasis and ulcerative colitis.</p>
<div class="lb-trans"><p>安進將在網站上提供一種藥物，零售價降低 80%。Amjevita 的原價為 1484 美元，但在 TrumpRx.gov 上售價為 299 美元。這種藥物用於治療類風濕關節炎、銀屑病和潰瘍性結腸炎。</p>
</div><p><strong>FOX NEWS POLL: VOTERS SOUND ALARM ON HEALTHCARE COSTS</strong></p>
<div class="lb-trans"><p><strong>福克斯新聞民調：選民對醫療成本發出警報</strong></p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2026/03/931/523/trump-dr-oz-trumprx.jpg?ve=1&amp;tl=1"/></p>
<p>President Donald Trump speaks as Administrator for the Centers for Medicare &amp; Medicaid Services Mehmet Oz looks on during an event on drug pricing in the South Court Auditorium on the White House campus Feb. 5, 2026, in Washington, D.C. (Nathan Howard/Getty Images)</p>
<div class="lb-trans"><p>特朗普總統在 2026 年 2 月 5 日於華盛頓特區白宮校園南法院禮堂舉行的藥品定價活動上發言，醫療保險和醫療補助服務中心的管理員 Mehmet Oz 在旁觀看。（Nathan Howard/Getty Images）</p>
</div><p>The company plans to list Aimovig and Repatha for discounts of 62%.</p>
<div class="lb-trans"><p>該公司計劃將 Aimovig 和 Repatha 的折扣定為 62%。</p>
</div><p>GSK will discount Incruse at 55% of the retail price. The drug treats COPD and will be listed at $159.</p>
<div class="lb-trans"><p>葛蘭素史克將 Incruse 的折扣定為零售價的 55%。該藥物用於治療慢性阻塞性肺病，售價為 159 美元。</p>
</div><p>GSK also plans to list Arnuity, Relenza and Anoro at discounts ranging from 10% to 51%.</p>
<div class="lb-trans"><p>葛蘭素史克還計劃將 Arnuity、Relenza 和 Anoro 的折扣範圍定為 10% 至 51%。</p>
</div><table>
<thead>
<tr>
<th>Ticker</th>
<th>Security</th>
<th>Last</th>
<th>Change</th>
<th>Change %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>AMGEN INC.</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>GSK PLC</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>股票代碼</th>
<th>證券</th>
<th>最新</th>
<th>變動</th>
<th>變動 %</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>安進</td>
<td>366.21</td>
<td>-1.58</td>
<td>-0.43%</td>
</tr>
<tr>
<td>GSK</td>
<td>葛蘭素史克</td>
<td>53.39</td>
<td>-0.89</td>
<td>-1.64%</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</div><p>&#34;GSK and Amgen connecting with TrumpRx.gov to offer prescription drugs directly to consumers at most-favored-nations pricing marks another milestone for President Trump’s affordability push,&#34; White House spokesman Kush Desai told FOX Business.</p>
<div class="lb-trans"><p>白宮發言人 Kush Desai 對 FOX Business 表示：&#34;葛蘭素史克和安進通過 TrumpRx.gov 直接向消費者提供處方藥，以最惠國定價的方式，標誌着特朗普總統在推動藥品可負擔性方面又一個里程碑。&#34;</p>
</div><p>&#34;TrumpRx.gov is just the beginning, however, as Americans are set to (receive) even greater drug pricing discounts, lower insurance premiums and more transparency when Congress passes President Trump’s Great Healthcare Plan.&#34;</p>
<div class="lb-trans"><p>&#34;然而，TrumpRx.gov 僅僅是個開始，隨着國會通過特朗普總統的偉大醫療計劃，美國人將獲得更大的藥品價格折扣、更低的保險費和更多的透明度。&#34;</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/12/931/523/pharmacy-tech.png?ve=1&amp;tl=1"/></p>
<p>Amgen will offer medication on the website that cuts 80% off the retail price. (George Frey/Bloomberg via Getty Images)</p>
<div class="lb-trans"><p>安進將在網站上提供一種藥物，零售價降低 80%。(George Frey/Bloomberg via Getty Images)</p>
</div><p>The Pharmaceutical Research and Manufacturers of America represents major drug companies.</p>
<div class="lb-trans"><p>美國製藥研究與製造商協會代表主要製藥公司。</p>
</div><p>CEO Stephen Ubl believes &#34;Government-imposed most-favored-nation policies would undermine U.S. competitiveness while doing nothing to address insurance practices that deny care and raise costs for patients.</p>
<div class="lb-trans"><p>首席執行官 Stephen Ubl 認為：&#34;政府強加的最惠國政策將削弱美國的競爭力，同時對解決拒絕醫療和提高患者成本的保險做法毫無幫助。&#34;</p>
</div><p><strong>HOUSE GOP SEEKS OFF-RAMP TO SKY-HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS</strong></p>
<div class="lb-trans"><p><strong>眾議院共和黨尋求解決數百萬美國人高昂醫療保險成本的出路</strong></p>
</div><p>&#34;These policies would siphon billions from American R&amp;D, slow the pace of cures and increase reliance on China for future innovation.&#34;</p>
<div class="lb-trans"><p>&#34;這些政策將從美國的研發中抽走數十億美元，減緩治癒的進程，並增加對中國未來創新的依賴。&#34;</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg/query-dGw9MSZ2ZT0x" alt="" original-src="https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/04/931/523/Pharmacy-drugs-Walgreens.jpg?ve=1&amp;tl=1"/></p>
<p>GSK will discount Incruse at 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
<div class="lb-trans"><p>葛蘭素史克將 Incruse 的折扣定為零售價的 55%。(Jeffrey Greenberg/Universal Images Group via Getty Images)</p>
</div><p>The White House is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut medical costs.</p>
<div class="lb-trans"><p>白宮正在推進對 TrumpRx.gov 的公告，因為美國人正在尋找降低醫療成本的方法。</p>
</div><p><strong>GET FOX BUSINESS ON THE GO BY CLICKING HERE</strong></p>
<div class="lb-trans"><p><strong>點擊這裏獲取福克斯商業新聞移動版</strong></p>
</div><p>Under the Biden administration, Bureau of Labor Statistics data shows, prescription drug costs increased 10.4% from January 2021 to January 2025. Under the Trump administration, prescription drug prices increased 0.2% from January 2025 through the latest data from February 2026.</p>
<div class="lb-trans"><p>根據拜登政府的數據顯示，勞工統計局的數據表明，從 2021 年 1 月到 2025 年 1 月，處方藥成本增加了 10.4%。而在特朗普政府期間，從 2025 年 1 月到 2026 年 2 月的最新數據，處方藥價格僅增加了 0.2%。</p>
</div>

特朗普擴大藥品折扣計劃，兩家制藥巨頭加入 TrumpRx